SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-16-666367
Filing Date
2016-08-01
Accepted
2016-08-01 14:40:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d252803dsc13d.htm SC 13D 41086
  Complete submission text file 0001193125-16-666367.txt   42295
Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Filed by) CIK: 0001236927 (see all company filings)

Type: SC 13D

Mailing Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034 949-725-4277
Madrigal Pharmaceuticals, Inc. (Subject) CIK: 0001673226 (see all company filings)

IRS No.: 453050834 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89582 | Film No.: 161796918